Trifluridine 20 mg & Tipiracil 8.19 mg Tablets

Get a Price/Quote

MOQ : 100 Packs

Trifluridine 20 mg & Tipiracil 8.19 mg Tablets Specification

Salt Composition
Trifluridine 20 mg & Tipiracil 8.19 mg

Dosage Form
Tablet

Indication
Used for treatment of metastatic colorectal cancer

Feature
Oral cytotoxic combination therapy

Ingredients
Trifluridine, Tipiracil

Application
Antineoplastic medicinal product

Physical Color/Texture
White to off-white, film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from moisture

Shelf Life
24 months

Packaging Type
Blister pack

Contraindications
Hypersensitivity to active substances

Regulatory Approval
WHO-GMP, US FDA, EMA, as applicable

Administration Route
Oral

Marketed Strengths
Trifluridine 20 mg & Tipiracil 8.19 mg per tablet

Product Code
Consult manufacturer

ATC Code
L01BX53

Pack Size
20 Tablets per pack

Prescription Status
Prescription only

Warnings
Use with caution in patients with hematological toxicity

Usage Restrictions
Not recommended in pregnancy and breastfeeding

Quality Standard
IP/BP/USP as applicable

Trifluridine 20 mg & Tipiracil 8.19 mg Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Trifluridine 20 mg & Tipiracil 8.19 mg Tablets

Experience the unbeatable efficacy of Trifluridine 20 mg & Tipiracil 8.19 mg Tablets, a popular and best-selling antineoplastic combination therapy. Delivered in fresh, blister-packed form with 20 tablets per pack, these tablets are indicated for the treatment of metastatic colorectal cancer. Manufactured under WHO-GMP, US FDA, and EMA guidelines, the product guarantees astounding quality and reliability. This oral, odorless, white to off-white film-coated tablet offers terrific ease of administration and is prescription-only for enhanced patient safety. Store below 25C for optimal shelf life. Distributed by trusted suppliers and traders across India.

Unmatched Antineoplastic Application

Trifluridine 20 mg & Tipiracil 8.19 mg Tablets are utilized as an effective cytotoxic oral therapy for adults with metastatic colorectal cancer. Specifically designed for human use, the tablets act directly within the body-targeting cancer cells systemically rather than relying on topical or localized treatments. Applied via the oral route, their action makes them a vital component in modern oncology, ideal for comprehensive disease management where conventional treatments may not suffice.

Flexible Payment and Rapid Supply Options

Our company is proud to offer competitive quotations for Trifluridine 20 mg & Tipiracil 8.19 mg Tablets, ensuring cost-effective access to this best-seller in the domestic market. With high supply ability, we assure express shipping across India and prompt delivery for consistent patient care. Payment terms are tailored for your convenience, and our responsive customer service is always available to discuss requirements or address queries efficiently.

FAQ's of Trifluridine 20 mg & Tipiracil 8.19 mg Tablets:

Q: How should Trifluridine 20 mg & Tipiracil 8.19 mg Tablets be administered?

A: This medication is administered orally, typically with water, as directed by your healthcare professional. It is important to follow your doctor's instructions regarding dosage and timing.

Q: What conditions are these tablets best used for?

A: These tablets are primarily indicated for use in adult patients with metastatic colorectal cancer, especially when other treatments have not achieved the desired results.

Q: When should Trifluridine & Tipiracil not be used?

A: These tablets should not be used in patients with a known hypersensitivity to Trifluridine, Tipiracil, or any tablet ingredients, and are contraindicated in pregnancy and breastfeeding.

Q: Where can I purchase Trifluridine & Tipiracil Tablets in India?

A: These tablets are available through licensed pharmaceutical suppliers and traders across India. Please consult with your local pharmacy for availability and a valid prescription is required.

Q: What safety precautions should be taken during usage?

A: Patients should be closely monitored for hematological toxicity. It is essential to use the medication under strict medical supervision, particularly in individuals with pre-existing blood disorders.

Q: What are the benefits of choosing this oral cytotoxic combination therapy?

A: This therapy offers a convenient oral administration, proven effectiveness against metastatic colorectal cancer, and is manufactured according to stringent quality standards, ensuring safety and reliability.

Tell us about your requirement